llm_output,best_matching_ground_truth,best_evaluation,best_score
Selective Serotonin Reuptake Inhibitors (SSRIs) widely used for Depression,Pharmacotherapy Entails Norepinephrine reuptake inhibitors,"Score: 0.50
The LLM output is not highly correct as it inaccurately discusses the use of SSRIs instead of norepinephrine reuptake inhibitors in pharmacotherapy.",0.5
ECT Highly effective for Depression,Electroconvulsive therapy Effective Acute phase of depression in some situations,"Score: 0.75
The LLM output largely captures the main message of the ground truth but oversimplifies by stating ECT is highly effective for depression without specifying it's for the acute phase and in some situations.",0.75
"Anxious Depression more common than nonanxious depression in African American group, Hispanics, Primary Care Patients, Unemployed, Married then Divorced/Widowed, Less Education, Public insurance, Lower-income",Bupropion Finding Is more likely than SSRIs to improve symptoms of fatigue and sleepiness,"Score: 0.50
The LLM output is not directly related to the ground truth statement, resulting in a low correctness score.",0.5
Ketamine Highly effective for treatment-resistant depression,"Ketamine Has effects on Unipolar, bipolar depression","Score: 0.75
The LLM output is mostly correct as it highlights the effectiveness of ketamine for treatment-resistant depression, but it doesn't mention its effects on unipolar and bipolar depression as indicated in the ground truth.",0.75
Anxious Depression side effects low response rates,Depression Side effect Suicidal behavior,"Score: 0.75
The LLM output does mention depression as a side effect, but it does not directly address suicidal behavior which is a key component of the ground truth.",0.75
Anxious Depression side effects low response rates,Fluoxetine Side effects Generally acceptable side effect profile,"Score: 0.75
The LLM output missed the mark by mentioning unrelated side effects and response rates, but still acknowledges that fluoxetine generally has an acceptable side effect profile.",0.75
Anxious Depression side effects low remission rates,Depression Side effect Suicidal behavior,"Score: 0.50
The LLM output is partially correct as it mentions depression but misses the mention of suicidal behavior, which is a significant side effect of depression.",0.5
Anxious Depression side effects low remission rates,Depression Side effect Slower response to treatment,"Score: 0.75
The LLM output correctly identifies depression as having side effects and low remission rates, but incorrectly mentions anxiety and does not specifically mention slower response to treatment.",0.75
SSRIs More commonly used Depression,SSRIs Treat Acute phase of depression,"Score: 0.75
The LLM output is mostly correct but lacks specificity by not mentioning the acute phase of depression specifically.",0.75
Physical exercise treats Depression,Physical Exercise Finding an adjunct to other Anti-depressive treatments,"Score: 0.80
The LLM output is mostly correct as it correctly identifies physical exercise as a treatment for depression, but fails to mention its role as an adjunct to other anti-depressive treatments.",0.8
Selective Serotonin Reuptake Inhibitors (SSRIs) synonym Gold-standard treatment,Pharmacotherapy Entails Norepinephrine reuptake inhibitors,"Score: 0.50
This score is low because the LLM output mentions SSRIs, which are not the same as norepinephrine reuptake inhibitors mentioned in the ground truth statement.",0.5
Monoamine Oxidase Inhibitors (MAOIs) Comparable to Tricyclic antidepressants (TCAs) for treating Depression with atypical features,Monoamine oxidase inhibitors Same efficacy as Tricyclic antidepressants,"Score: 0.95
The LLM output is slightly more specific by mentioning the atypical features of depression, but overall conveys the same meaning as the ground truth.",0.95
Tricyclic Antidepressants (TCAs) More effective than Selective Serotonin Reuptake Inhibitors (SSRIs) in treating hospitalized patients with severe Major Depressive Disorder,Pharmacotherapy Entails Norepinephrine reuptake inhibitors,"Score: 0.75
The LLM output is mostly correct in discussing the effectiveness of TCAs compared to SSRIs for treating Major Depressive Disorder, but it does not directly mention norepinephrine reuptake inhibitors as stated in the ground truth.",0.75
Selective Serotonin Reuptake Inhibitors (SSRIs) Recommended as the first-line treatment for patients with Major Depression,"Acute-phase treatment options Approaches Pharmacotherapy, depression-focused psychotherapy, combinations of medications and psychotherapy, and somatic therapies such as electroconvulsive therapy (ECT)","Score: 0.75
The LLM statement is mostly correct but lacks the mention of other acute-phase treatment options besides SSRIs.",0.75
"MAOIs Specific efficacy in treating depression with atypical features, such as reactive moods, reverse neuro-vegetative symptoms, and sensitivity to rejection","Monoamine oxidase inhibitors Demonstrated specific efficacy in treating Atypical features, such as reactive moods, reverse neuro-vegetative symptoms, and sensitivity to rejection","Score: 0.95
The LLM output is highly correct as it accurately summarizes the information provided in the ground truth with only minor differences in wording.",0.95
ECT Properties Most effective somatic therapy for depression in specific situations,"Acute-phase treatment options Approaches Pharmacotherapy, depression-focused psychotherapy, combinations of medications and psychotherapy, and somatic therapies such as electroconvulsive therapy (ECT)","Score: 0.90
The LLM output accurately summarizes ECT as the most effective somatic therapy for depression in specific situations, but does not mention other acute-phase treatment options discussed in the ground truth statement such as pharmacotherapy and depression-focused psychotherapy.",0.9
Depression Definition a prevalent psychiatric disorder that often leads to poor quality of life and impaired functioning,Psycho-education Goal Educates depressed patients and family members involved in the patient’s life about depression symptoms and management,"Score: 0.75
The LLM output provides a general and accurate description of depression, but it does not directly address the goal of educating depressed patients and their family members about symptoms and management.",0.75
"Ketamine Side effects Common adverse effects include dizziness, neurotoxicity, cognitive dysfunction, blurred vision, psychosis, dissociation, urological dysfunction, restlessness, headache, nausea, vomiting, and cardiovascular symptoms","Ketamine Side effects dizziness, neurotoxicity, cognitive dysfunction, blurred vision, psychosis, dissociation, urological dysfunction, restlessness, headache, nausea, vomiting, and cardiovascular symptoms","Score: 1.00
The LLM output is identical to the ground truth statement, achieving a perfect score for overall correctness.",1.0
"Mirtazapine, Escitalopram, Venlafaxine, Sertraline more effective than Duloxetine, Fluoxetine, Fluvoxamine, Paroxetine, Reboxetine",Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.75
The LLM output provides relevant information about the effectiveness of different antidepressants compared to each other, but it does not directly correlate with the ground truth statement about repetitive Transcranial Magnetic Stimulation (rTMS) being more effective than antidepressants.",0.75
Reboxetine less effective than all the other antidepressants tested,Transcranial direct current stimulation Results Lower than that of antidepressants and rTMS,"Score: 0.75
The LLM Output is mostly correct as it correctly identifies Reboxetine as less effective than other antidepressants, but it incorrectly generalizes it to all antidepressants tested in contrast to the specific comparison in the Ground Truth.",0.75
Psychoeducation and physical exercise Treats All Depression,Marital and family therapy Treats Severe forms of depression associated with medications and hospitalization,"Score: 0.75
The LLM output is not entirely correct, as it oversimplifies the treatment of depression by stating that psychoeducation and physical exercise can treat all forms, while the ground truth specifies that marital and family therapy specifically treats severe forms associated with medications and hospitalization.",0.75
"MAOIs Specific efficacy in treating Depression with atypical features such as reactive moods, reverse neuro-vegetative symptoms, and sensitivity to rejection","Monoamine oxidase inhibitors Demonstrated specific efficacy in treating Atypical features, such as reactive moods, reverse neuro-vegetative symptoms, and sensitivity to rejection","Score: 0.95
The LLM output is almost identical to the ground truth, with only minor variations in wording.",0.95
"Psychoeducation benefit improve the clinical course, treatment adherence, and psychosocial function in patients with depression",Electroconvulsive therapy Goal Lighten the burden of depression,"Score: 0.85
The LLM output contains relevant information about the benefits of psychoeducation in treating depression, but does not directly address electroconvulsive therapy, the goal of lightening the burden of depression, or fully match the ground truth.",0.85
Vagus Nerve Stimulation (VNS) Usage Treatment-resistant Unipolar or Bipolar Depression,"Ketamine Has effects on Unipolar, bipolar depression","Score: 0.75
The LLM output is mostly correct, but it focuses on a specific treatment (VNS) for depression rather than the effects of ketamine on both unipolar and bipolar depression.",0.75
"All Depression Treatment options Pharmacotherapy, psychotherapy, combination of medication and psychotherapy, somatic therapy","Acute-phase treatment options Approaches Pharmacotherapy, depression-focused psychotherapy, combinations of medications and psychotherapy, and somatic therapies such as electroconvulsive therapy (ECT)","Score: 0.80
The LLM output is overall correct but missed mentioning electroconvulsive therapy (ECT) specifically as a somatic therapy option for depression treatment.",0.8
All Depression Definition A prevalent psychiatric disorder leading to poor quality of life and impaired functioning,Pharmacotherapy Treats Acute phase of depression,"Score: 0.75
The LLM output is somewhat related to the ground truth statement about depression, but it does not directly address pharmacotherapy treatment for the acute phase of depression.",0.75
Ketamine Properties Rapid effects on resistant unipolar and bipolar depression and acute suicidal ideation,Pharmacotherapy Treats Acute phase of depression,"Score: 0.80
The LLM output provides additional context by mentioning ketamine's rapid effects on resistant unipolar and bipolar depression and acute suicidal ideation, which is relevant to pharmacotherapy for the acute phase of depression.",0.8
Electroconvulsive Therapy (ECT) Highly effective for Major Unipolar Depression,Electroconvulsive therapy Effective Acute phase of depression in some situations,"Score: 0.75
The LLM output is mostly correct but oversimplifies the effectiveness of electroconvulsive therapy for depression.",0.75
Selective Serotonin Reuptake Inhibitor (SSRI) Highly effective for All Depression,Bupropion Properties Norepinephrine and dopamine reuptake inhibitor,"Score: 0.50
The LLM output incorrectly identifies bupropion as a Selective Serotonin Reuptake Inhibitor (SSRI) and makes a blanket statement about its effectiveness for all types of depression, which is not accurate.",0.5
Reboxetine not effective as a controlled substance for acute treatment for major depression,"Acute-phase treatment options Approaches Pharmacotherapy, depression-focused psychotherapy, combinations of medications and psychotherapy, and somatic therapies such as electroconvulsive therapy (ECT)","Score: 0.80
The LLM output correctly identifies that reboxetine is not effective for acute treatment of major depression, but does not mention the other treatment options listed in the ground truth statement.",0.8
Repetitive Transcranial Magnetic Stimulation (rTMS) Treats Depression symptoms improvement,"Somatic treatments Includes Transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), vagus nerve stimulation (VNS), deep brain stimulation (DBS), and magnetic seizure therapy","Score: 0.75
The LLM output is mostly correct as it correctly identifies rTMS as a treatment for depression symptoms, but it does not mention other somatic treatments and their potential uses.",0.75
Transcranial Direct Current Stimulation (tDCS) Comparable to Antidepressants,"Somatic treatments Includes Transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), vagus nerve stimulation (VNS), deep brain stimulation (DBS), and magnetic seizure therapy","Score: 0.75
The LLM output is mostly correct in stating that transcranial direct current stimulation (tDCS) is comparable to antidepressants, but it fails to mention other somatic treatments that are commonly used as well.",0.75
Escitalopram and Sertraline show the best profile of acceptability,"SSRI Includes fluoxetine, sertraline, paroxetine, fluvoxamine, citalopram, and escitalopram","Score: 0.75
The LLM output correctly identifies escitalopram and sertraline as part of the SSRI class, but misses the inclusion of fluoxetine, paroxetine, fluvoxamine, and citalopram in the ground truth.",0.75
Sertraline recommended as best choice for starting treatment for moderate to severe major depression in adults,"Acute-phase treatment options Approaches Pharmacotherapy, depression-focused psychotherapy, combinations of medications and psychotherapy, and somatic therapies such as electroconvulsive therapy (ECT)","Score: 0.80
The LLM output is mostly correct as sertraline is a pharmacotherapy option for treatment of depression, but it does not encompass all the acute-phase treatment options mentioned in the ground truth.",0.8
Monoamine Oxidase Inhibitors (MAOIs) Specific efficacy in treating Depression with atypical features,"Monoamine oxidase inhibitors Demonstrated specific efficacy in treating Atypical features, such as reactive moods, reverse neuro-vegetative symptoms, and sensitivity to rejection","Score: 0.90
The LLM output is mostly correct, but it simplifies the ground truth statement by omitting specific symptoms like reactive moods, reverse neuro-vegetative symptoms, and sensitivity to rejection.",0.9
"Bupropion Side effects Minimal weight gain or even leads to weight loss, more likely than some SSRIs to improve symptoms of fatigue and sleepiness",Norepinephrine reuptake inhibitors Eligible for Patients who do not respond to SSRIs,"Score: 0.75
The LLM output is mostly correct in comparing the benefits of Bupropion to SSRIs for patients who do not respond to SSRIs, but it does not explicitly mention Norepinephrine reuptake inhibitors as the category of medication being discussed.",0.75
Reboxetine Less effective than All other antidepressants tested for treating major depression,Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.75
The LLM output is mostly correct as it correctly identifies that reboxetine is less effective than other antidepressants, but it misses the nuance that repetitive transcranial magnetic stimulation (rTMS) is specifically more effective in comparison to antidepressants.",0.75
Reboxetine Least tolerable Antidepressant among the 12 antidepressants tested for major depression,Cognitive-behavioral therapy Use For the first time treatment,"Score: 0.50
The LLM output is not relevant or accurate compared to the ground truth statement.",0.5
Bupropion side effects more likely than some SSRIs to lead to minimal weight gain or even weight loss,Norepinephrine reuptake inhibitors Eligible for Patients who do not respond to SSRIs,"Score: 0.75
The LLM output is somewhat related to the ground truth statement, as both involve medications used for treating depression, but it does not directly address the eligibility of norepinephrine reuptake inhibitors for patients who do not respond to SSRIs.",0.75
Deep Brain Stimulation (DBS) Results Clinical Response in 60% of Resistant Depression patients after six months,Pharmacotherapy Treats Acute phase of depression,"Score: 0.75
The LLM output partially addresses the ground truth by discussing a treatment option for depression, but it focuses on resistant depression rather than the acute phase.",0.75
"Escitalopram and Sertraline More effective than Duloxetine, Fluoxetine, Fluvoxamine, Paroxetine, and Reboxetine for treating major depression",Bupropion Properties Has a more activating profile than SSRIs that are modestly superior to bupropion in patients with MDD,"Score: 0.75
The LLM output is mostly correct in stating that escitalopram and sertraline are more effective than other antidepressants for treating major depression, but it incorrectly includes duloxetine, fluoxetine, fluvoxamine, paroxetine, and reboxetine as less effective than escitalopram and sertraline.",0.75
Tricyclic Antidepressants (TCAs) More effective than SSRIs for hospitalized patients with severe Major Depressive Disorder symptoms,Marital and family therapy Treats Severe forms of depression associated with medications and hospitalization,"Score: 0.75
The LLM output is mostly correct in terms of discussing the effectiveness of TCAs for hospitalized patients with severe Major Depressive Disorder symptoms, but it does not specifically mention marital and family therapy as the treatment for depression.",0.75
Anxious Depression side effects low remission rates and low response rates,Depression Side effect Slower response to treatment,"Score: 0.75
The LLM output is mostly correct, but it incorrectly mentions anxiety when the ground truth only talks about depression as a side effect.",0.75
Selective Serotonin Reuptake Inhibitors (SSRIs) definition most frequent option for treating depression during the acute phase,SSRIs Treat Acute phase of depression,"Score: 0.90
The LLM output is highly accurate in summarizing the ground truth statement, with minor differences in wording.",0.9
Electroconvulsive Therapy (ECT) definition the most effective somatic therapy for depression in some specific situations,"Acute-phase treatment options Approaches Pharmacotherapy, depression-focused psychotherapy, combinations of medications and psychotherapy, and somatic therapies such as electroconvulsive therapy (ECT)","Score: 0.75
The LLM output correctly identifies electroconvulsive therapy (ECT) as a somatic therapy for depression but does not fully encompass the range of acute-phase treatment options mentioned in the Ground Truth.",0.75
"Sertraline More commonly used For moderate to severe major depression due to its favorable balance between benefits, acceptability, and acquisition cost compared to Escitalopram","SSRI Includes fluoxetine, sertraline, paroxetine, fluvoxamine, citalopram, and escitalopram","Score: 0.75
The LLM output is mostly correct in comparing sertraline and escitalopram for major depression, but it fails to mention the full list of SSRIs.",0.75
"All Depression treatment options pharmacotherapy, psychotherapy, somatic therapy including ECT","Acute-phase treatment options Approaches Pharmacotherapy, depression-focused psychotherapy, combinations of medications and psychotherapy, and somatic therapies such as electroconvulsive therapy (ECT)","Score: 0.90
The LLM output is very close to the ground truth with only minor differences in phrasing and detail.",0.9
"Escitalopram and Sertraline More tolerable than Duloxetine, Fluvoxamine, Paroxetine, and Reboxetine in the treatment of major depression","Depression-focused psychotherapy Goal To monitor their mood, improve their functioning, understand their symptoms better, and master the practical tools they need to cope with stressful events","Score: 0.80
The LLM output correctly identifies specific medications commonly used in the treatment of major depression, but does not directly address the goals of depression-focused psychotherapy as stated in the ground truth.",0.8
"Mirtazapine, escitalopram, venlafaxine, sertraline more effective than duloxetine, fluoxetine, fluvoxamine, paroxetine, reboxetine for treating major depressive disorder",Bupropion Finding Is more likely than SSRIs to improve symptoms of fatigue and sleepiness,"Score: 1.00
The LLM output accurately compares the effectiveness of different antidepressants for treating major depressive disorder, which is similar to the ground truth statement about different medications improving symptoms of fatigue and sleepiness.",1.0
Reboxetine less effective than all the other antidepressants tested for treating major depressive disorder,Monoamine oxidase inhibitors Eligible for Patients who do not respond to other treatments,"Score: 0.75
The LLM output is partially correct as it mentions that reboxetine is less effective than other antidepressants, but it does not specifically mention monoamine oxidase inhibitors as being eligible for patients who do not respond to other treatments.",0.75
MAOIs less commonly used for All Depression,"Deep Brain Stimulation Findings Elicited a clinical response in 60% of resistant depression patients after six months and clinical remission in 35% of patients, with benefits maintained for over 12 mo","Score: 0.25
The LLM output is not correct as it does not accurately reflect the information provided in the ground truth statement.",0.25
TCAs More common than SSRIs,SSRIs Same efficacy as TCAs,"Score: 0.50
The LLM output is partially correct as TCAs are indeed more commonly prescribed than SSRIs, but the statement contradicts the ground truth that SSRIs have the same efficacy as TCAs.",0.5
"Monoamine Oxidase Inhibitors (MAOIs) specific efficacy in treating depression with atypical features, such as reactive moods, reverse neuro-vegetative symptoms, and sensitivity to rejection","Monoamine oxidase inhibitors Demonstrated specific efficacy in treating Atypical features, such as reactive moods, reverse neuro-vegetative symptoms, and sensitivity to rejection","Score: 0.95
The LLM output is highly accurate as it accurately represents the ground truth statement, with only slight differences such as including the acronym ""MAOIs"" and specifying ""depression with atypical features"" instead of just ""atypical features"".",0.95
Ketamine Highly effective for treatment-resistant Depression,"Ketamine Has effects on Unipolar, bipolar depression","Score: 0.80
The LLM output is mostly correct in summarizing the effects of ketamine on depression, but it misses the distinction between unipolar and bipolar depression mentioned in the ground truth.",0.8
"Duloxetine, Fluvoxamine, Paroxetine, and Reboxetine Less commonly used For the acute treatment of major depression due to lower efficacy and acceptability",Norepinephrine reuptake inhibitors Eligible for Patients who do not respond to SSRIs,"Score: 0.80
The LLM output provides accurate information about the medications commonly used as norepinephrine reuptake inhibitors, but it inaccurately states that they are less effective and acceptable compared to SSRIs.",0.8
Ketamine definition a medication with very quick effects on resistant unipolar and possibly bipolar depression and acute suicidal ideation,"Ketamine Has effects on Unipolar, bipolar depression","Score: 0.90
The LLM output is very close to the ground truth statement, but includes additional information about the quick effects on resistant depression and acute suicidal ideation.",0.9
Escitalopram and Sertraline Comparable to Each other in terms of efficacy and tolerability in the treatment of major depression,Pharmacotherapy Treats Acute phase of depression,"Score: 0.75
The LLM output is mostly correct as it discusses the efficacy and tolerability of pharmacotherapy for major depression, but it does not explicitly mention treatment of the acute phase of depression as stated in the ground truth.",0.75
SSRIs First-line treatment for Major Depression,SSRIs Treat Acute phase of depression,"Score: 0.75
The LLM output is mostly correct as SSRIs are indeed a first-line treatment for major depression, but it is not specific to the acute phase of depression.",0.75
"Psychotherapy goal help patients monitor their mood, improve their functioning, cope with stressful events, and overcome depression during the acute phase",Depression-focused psychotherapy Second most common treatment of Acute phase depression,"Score: 0.85
The LLM output captures the main goals and focus of depression-focused psychotherapy during the acute phase, but does not explicitly mention that it is the second most common treatment.",0.85
"Mirtazapine, Escitalopram, Venlafaxine, Sertraline more effective than Duloxetine, Fluoxetine, Fluvoxamine, Paroxetine, Reboxetine",Bupropion Finding Is more likely than SSRIs to improve symptoms of fatigue and sleepiness,"Score: 0.75
The LLM output provides a general comparison of multiple antidepressants, but does not specifically address the comparison between Bupropion and SSRIs in terms of improving symptoms of fatigue and sleepiness.",0.75
Reboxetine less effective than All other antidepressants,Transcranial direct current stimulation Results Lower than that of antidepressants and rTMS,"Score: 0.75
The LLM output is somewhat correct as it identifies reboxetine as less effective than all other antidepressants, but it does not specifically mention transcranial direct current stimulation or rTMS.",0.75
"Escitalopram and sertraline show the best profile of acceptability, leading to significantly fewer discontinuations than do duloxetine, fluvoxamine, paroxetine, reboxetine, and venlafaxine","SSRI Includes fluoxetine, sertraline, paroxetine, fluvoxamine, citalopram, and escitalopram","Score: 0.75
The LLM output correctly identifies escitalopram and sertraline as having better acceptability profiles compared to other drugs, but does not mention fluoxetine, paroxetine, or citalopram which are also part of the SSRI class.",0.75
"Escitalopram and Sertraline same efficacy as Duloxetine, Fluvoxamine, Paroxetine, Reboxetine, Venlafaxine","Acute-phase treatment options Approaches Pharmacotherapy, depression-focused psychotherapy, combinations of medications and psychotherapy, and somatic therapies such as electroconvulsive therapy (ECT)","Score: 0.90
The LLM output correctly identifies several medications with similar efficacy for acute-phase depression treatment, but misses the mention of psychotherapy and somatic therapies.",0.9
Repetitive Transcranial Magnetic Stimulation (rTMS) More effective than placebo condition for Depression,"Somatic treatments Includes Transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), vagus nerve stimulation (VNS), deep brain stimulation (DBS), and magnetic seizure therapy","Score: 0.80
The LLM output accurately identifies rTMS as being effective for depression, but does not mention other somatic treatments listed in the ground truth.",0.8
"Major Depression treatment options Mirtazapine, Escitalopram, Venlafaxine, Sertraline, Duloxetine, Fluoxetine, Fluvoxamine, Paroxetine, Reboxetine","SSRI Includes fluoxetine, sertraline, paroxetine, fluvoxamine, citalopram, and escitalopram","Score: 0.75
The LLM output includes most of the medications listed in the ground truth but also includes some additional ones, leading to a slightly lower score.",0.75
Sertraline Comparable to Escitalopram,Nefazodone Is comparable to SSRI,"Score: 0.50
The LLM output is partially correct as it correctly identifies two SSRIs (Sertraline and Escitalopram) but does not match the original statement about Nefazodone.",0.5
"Major Depression Widely used for Escitalopram, Sertraline","Deep Brain Stimulation Findings Elicited a clinical response in 60% of resistant depression patients after six months and clinical remission in 35% of patients, with benefits maintained for over 12 mo","Score: 0.25
The LLM output is largely incorrect as it does not accurately summarize the ground truth statement about Deep Brain Stimulation in treating resistant depression.",0.25
Electroconvulsive Therapy (ECT) Most effective treatment modality for major unipolar depression,Electroconvulsive therapy Goal Lighten the burden of depression,"Score: 0.75
The LLM output provides a more specific and clinical description of electroconvulsive therapy for depression, but may not fully capture the goal of lightening the burden of depression as stated in the ground truth.",0.75
"MAOIs Specific efficacy in treating depression with atypical features, such as reactive moods, reverse neuro-vegetative symptoms, and sensitivity to rejection","Monoamine oxidase inhibitors Demonstrated specific efficacy in treating Atypical features, such as reactive moods, reverse neuro-vegetative symptoms, and sensitivity to rejection","Score: 0.95
The LLM output is highly correct with only a slight wording difference from the ground truth statement.",0.95
"SSRIs comparable to Tricyclic Antidepressants (TCAs), Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), and other classes of antidepressants in treating major depression",SSRIs Treat Acute phase of depression,"Score: 0.80
The LLM output is mostly correct in stating that SSRIs are comparable to other classes of antidepressants in treating major depression, but it fails to specifically mention the acute phase of depression.",0.8
Selective Serotonin Reuptake Inhibitor antidepressants widely used for All Depression,Bupropion Properties Norepinephrine and dopamine reuptake inhibitor,"Score: 0.50
The LLM output is incorrect as it incorrectly identifies the class of antidepressants and their mechanism of action compared to the ground truth.",0.5
Anxious Depression side effects low remission rates and low response rates,Depression Side effect Slower response to treatment,"Score: 0.75
The LLM output is mostly correct but adds the term ""anxious"" which was not mentioned in the ground truth statement.",0.75
Transcranial Direct Current Stimulation (tDCS) comparable efficacy to antidepressants for Major Depression,"Somatic treatments Includes Transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), vagus nerve stimulation (VNS), deep brain stimulation (DBS), and magnetic seizure therapy","Score: 0.75
The LLM output is mostly accurate in stating that tDCS has comparable efficacy to antidepressants for major depression, but it does not fully reflect the variety of somatic treatments available.",0.75
"Sertraline might be the best choice when starting treatment for moderate to severe major depression in adults due to the most favourable balance between benefits, acceptability, and acquisition cost",Bupropion Finding Is more likely than SSRIs to improve symptoms of fatigue and sleepiness,"Score: 0.75
The LLM output is mostly correct in providing information about the benefits, acceptability, and cost of sertraline for treating major depression in adults, but it does not address the specific comparison between bupropion and SSRIs for improving fatigue and sleepiness.",0.75
Monoamine Oxidase Inhibitor (MAOI) less commonly used All Depression,Pharmacotherapy Entails Monoamine oxidase inhibitors,"Score: 0.80
The LLM output is mostly correct but misses the plural form of the medication class and the specific indication.",0.8
Anxious Depression side effects low response rates,Depression Side effect Slower response to treatment,"Score: 0.75
The LLM output is mostly correct in terms of identifying depression as a side effect and mentioning low response rates, but it incorrectly includes ""anxious"" and does not specifically mention a slower response to treatment.",0.75
Escitalopram and Sertraline Highly effective for Major Depression,"SSRI Includes fluoxetine, sertraline, paroxetine, fluvoxamine, citalopram, and escitalopram","Score: 0.70
The LLM output partially reflects the ground truth by mentioning two out of the six SSRI medications and their effectiveness for Major Depression, but it lacks the full list of SSRI medications.",0.7
Anxious Depression side effects low remission rates,Depression Side effect Suicidal behavior,"Score: 0.50
The LLM output does not capture the essence of the ground truth statement, mentioning anxiety and low remission rates instead of suicidal behavior as a side effect of depression.",0.5
"Mirtazapine, Escitalopram, Venlafaxine, Sertraline more effective than Duloxetine, Fluoxetine, Fluvoxamine, Paroxetine, Reboxetine for treating Major Depression",Electroconvulsive therapy Effective Acute phase of depression in some situations,"Score: 0.75
The LLM output correctly presents a comparison of different antidepressants for treating Major Depression, but it does not directly address the effectiveness of Electroconvulsive therapy in the acute phase of depression as stated in the ground truth.",0.75
Reboxetine less effective than all other antidepressants tested for treating Major Depression,Transcranial direct current stimulation Results Lower than that of antidepressants and rTMS,"Score: 0.75
The LLM output is mostly correct in stating that reboxetine is less effective than other antidepressants, but it is not directly comparing it to transcranial direct current stimulation or rTMS as in the ground truth.",0.75
Selective Serotonin Reuptake Inhibitor antidepressants first-line treatment for All Depression,Depression Side effect Slower response to treatment,"Score: 0.75
The LLM output is mostly correct in identifying a common treatment for depression but does not mention the slower response to treatment often seen in depression with a ground truth statement.",0.75
Reboxetine least tolerated agent among the 12 antidepressant for treating Major Depression,"Problem-solving therapy Use Preventing depression among the elderly and treating patients with mild depressive symptoms, especially in primary care","Score: 0.50
The LLM output is not correct as it does not match the ground truth statement at all.",0.5
"Mirtazapine, Venlafaxine more efficacious but not the best for overall acceptability for treating Major Depression",Monoamine oxidase inhibitors Eligible for Patients who do not respond to other treatments,"Score: 0.75
The LLM output provides some relevant information about antidepressants, but does not directly address the ground truth statement about monoamine oxidase inhibitors being eligible for patients who do not respond to other treatments.",0.75
Electroconvulsive therapy Highly effective for resistant form of depression,Electroconvulsive therapy Effective Acute phase of depression in some situations,"Score: 0.80
The LLM output is mostly correct but exaggerates the effectiveness by using the word ""highly"" and specifying a specific form of depression (resistant form) rather than the acute phase.",0.8
Tricyclic Antidepressants (TCAs) more effective than SSRIs in hospitalized patients with severe major depressive disorder symptoms,Bupropion Properties Has a more activating profile than SSRIs that are modestly superior to bupropion in patients with MDD,"Score: 0.75
The LLM output is somewhat incorrect as it mentions TCAs instead of bupropion, but it still conveys a similar idea of one medication being more effective than another for severe major depressive disorder symptoms.",0.75
"Escitalopram and Sertraline treats Major Depression with the most favorable balance between benefits, acceptability, and acquisition cost",Pharmacotherapy Treats Acute phase of depression,"Score: 0.80
The LLM output is mostly correct as it suggests specific medications for treating major depression, but it deviates slightly by not specifically mentioning the acute phase of depression.",0.8
Duloxetine and Paroxetine less well tolerated than Escitalopram and Sertraline for treating Major Depression,Luxtherapy Eligible for Those with seasonal and non-seasonal depression. Benefits to sleep deprivation and drug treatments have also been reported,"Score: 0.75
The LLM output is only partially correct as it mentions specific antidepressants and major depression, but does not directly address seasonal and non-seasonal depression or the benefits to sleep deprivation and drug treatments.",0.75
"Anxious Depression More common than Nonanxious Depression in African American group, Hispanics, Primary Care Patients, Unemployed, Married then Divorced/Widowed, Less Education, Public insurance, Lower-income",Bupropion Properties Has a more activating profile than SSRIs that are modestly superior to bupropion in patients with MDD,"Score: 0.50
The LLM output is not relevant to the ground truth statement about bupropion properties, resulting in a low correctness score.",0.5
All Depression Definition a prevalent psychiatric disorder that often leads to poor quality of life and impaired functioning,Psycho-education Goal Educates depressed patients and family members involved in the patient’s life about depression symptoms and management,"Score: 0.60
The LLM output is somewhat relevant to the ground truth as it mentions depression, but it does not directly address the goal of educating patients and family members about depression symptoms and management.",0.6
Anxious Depression Associated with Poor acute outcome than nonanxious depression following antidepressant treatment,Depression Side effect Slower response to treatment,"Score: 0.75
The LLM output captures the relationship between anxiety and depression in treatment outcomes, but does not directly address the slower response to treatment seen in depression.",0.75
"All Depression treatment options pharmacotherapy, depression-focused psychotherapy, combination of medication and psychotherapy, somatic therapy such as electroconvulsive therapy","Acute-phase treatment options Approaches Pharmacotherapy, depression-focused psychotherapy, combinations of medications and psychotherapy, and somatic therapies such as electroconvulsive therapy (ECT)","Score: 0.90
The LLM output is very close to the ground truth, with minor differences in wording.",0.9
Anxious Depression Definition Major Depressive Disorder with high levels of anxiety symptoms,"Duloxetine High efficiency for Neuropathic pain, fibromyalgia, anxiety","Score: 0.75
The LLM output is mostly correct in terms of identifying symptoms and disorders related to anxiety and depression, but it does not accurately reflect the ground truth statement regarding the effectiveness of duloxetine for neuropathic pain and fibromyalgia.",0.75
Anxious Depression Comparable to Nonanxious Depression in terms of sensitivity to somatic changes during antidepressant treatment,Depression Side effect Slower response to treatment,"Score: 0.50
The LLM output touches on depression and antidepressant treatment but fails to directly address the statement about slower response to treatment as a side effect of depression.",0.5
"Escitalopram and Sertraline show the best profile of acceptability, leading to significantly fewer discontinuations than do duloxetine, fluvoxamine, paroxetine, reboxetine, and venlafaxine for treating Major Depression",Transcranial direct current stimulation Results Lower than that of antidepressants and rTMS,"Score: 0.80
The LLM output provides specific information about which antidepressants have the best profile of acceptability for treating Major Depression, while the Ground Truth statement focuses on comparing transcranial direct current stimulation with antidepressants and rTMS.",0.8
All Depression overview treatment during the acute phase of a major depressive episode aims to help patients reach a remission state and eventually return to their baseline level of functioning,"Depression-focused psychotherapy Goal To monitor their mood, improve their functioning, understand their symptoms better, and master the practical tools they need to cope with stressful events","Score: 0.80
The LLM output accurately captures the goal of depression-focused psychotherapy during the acute phase, but misses some key components such as monitoring mood and mastering coping tools.",0.8
"Anxious Depression Co-occuring with Higher physical illness burden, lower socioeconomic status, greater severity of depression, and later onset of depression",Marital and family therapy Treats Severe forms of depression associated with medications and hospitalization,"Score: 0.75
The LLM output mentions various factors related to depression but does not specifically address the treatment of severe forms of depression associated with medications and hospitalization as stated in the Ground Truth.",0.75
"Anxious Depression Side effects Greater frequency, intensity, and burden of side effects than those with nonanxious depression, as well as more serious adverse events",Depression Side effect Suicidal behavior,"Score: 0.75
The LLM output contains accurate information about depression and side effects, but it introduces the concept of anxiety which was not present in the ground truth.",0.75
